Newsletter Archive
-
07.06.26 -- Solving Glycoengineering Challenges Could Begin At The Cell Line
7/6/2026
07/06/26 Bioprocess Online Newsletter
-
07.04.26 -- Maintaining Compliance And Understanding FDA Expectations
7/4/2026
07/04/26 Bioprocess Online Newsletter
-
07.03.26 -- STREAM Edition: Cell Therapy Without The Cells: Building A Therapeutic Secretome With Noveome Biotherapeutics' Larry Brown, Sc.D.
7/3/2026
07/03/26 Bioprocess Online Newsletter
-
07.03.26 -- Prioritize Speed And Precision In Biosimilar Development By Aligning With The Latest FDA Guidance
7/3/2026
07/03/26 Bioprocess Online Newsletter
-
07.02.26 -- New Podcast Episodes: A Midyear Look At Life Sciences, Derisking CNS Drug Development, In Vivo Gene Editing
7/2/2026
07/02/26 Bioprocess Online Newsletter
-
07.02.26 -- Is Your AI Model Trustworthy And Credible In GMP Processes?
7/2/2026
07/02/26 Bioprocess Online Newsletter
-
07.01.26 -- Having Achieved Quality, Downstream Teams Seek To Maximize Viral Vector Recovery
7/1/2026
07/01/26 Bioprocess Online Newsletter
-
06.30.26 -- Where Should AI Fit In Validation?
6/30/2026
06/30/26 Bioprocess Online Newsletter
-
06.30.26 -- Mastering Biotech's Insourcing/Outsourcing Trade-Offs
6/30/2026
06/30/26 Bioprocess Online Newsletter
-
06.29.26 -- Application Of Process Analytical Technology In ADC And Bioconjugation Processes
6/29/2026
06/29/26 Bioprocess Online Newsletter